These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37317722)

  • 1. Validation and usability of modified palmoplantar psoriasis area and severity index in patients with palmoplantar psoriasis: A prospective longitudinal cohort study.
    Nagendran A; Hanumanthu V; Dogra S; Narang T; Venkata Maha Pinnaka L
    Indian J Dermatol Venereol Leprol; 2023 May; ():1-8. PubMed ID: 37317722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Palmoplantar Psoriasis: Epidemiological and Clinical Features and Impact on Quality of Life.
    Elinkichari D; Rabhi F; Jaber K; Dhaoui R
    Dermatol Pract Concept; 2024 Jul; 14(3):. PubMed ID: 39122505
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of Clinical and Demographic Factors With the Severity of Palmoplantar Pustulosis.
    Benzian-Olsson N; Dand N; Chaloner C; Bata-Csorgo Z; Borroni R; Burden AD; Cooper HL; Cornelius V; Cro S; Dasandi T; Griffiths CEM; Kingo K; Koks S; Lachmann H; McAteer H; Meynell F; Mrowietz U; Parslew R; Patel P; Pink AE; Reynolds NJ; Tanew A; Torz K; Trattner H; Wahie S; Warren RB; Wright A; Barker JN; Navarini AA; Smith CH; Capon F;
    JAMA Dermatol; 2020 Nov; 156(11):1216-1222. PubMed ID: 32936291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the Efficacy and Safety of Apremilast and Methotrexate in Patients with Palmoplantar Psoriasis: A Randomized Controlled Trial.
    Kt S; Thakur V; Narang T; Dogra S; Handa S
    Am J Clin Dermatol; 2021 May; 22(3):415-423. PubMed ID: 33712987
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of palmoplantar psoriasis with infliximab: a randomized, double-blind placebo-controlled study.
    Bissonnette R; Poulin Y; Guenther L; Lynde CW; Bolduc C; Nigen S
    J Eur Acad Dermatol Venereol; 2011 Dec; 25(12):1402-8. PubMed ID: 21349113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical characteristics, quality of life and risk factors for severity in palmoplantar pustulosis: a cross-sectional, multicentre study of 263 patients.
    Sarıkaya Solak S; Kara Polat A; Kilic S; Oguz Topal I; Saricaoglu H; Karadag AS; Canpolat F; Kartal SP; Deveci BN; Kacar N; Polat Ekinci A; Guner R; Polat M; Dogan G; Guler Ozden M; Bulbul Baskan E; Ozaydin Yavuz G; Adisen E; Gulekon A; Tanribilir ME; Yilmaz O; Akman Karakas A; Ozturk P; Didar Balci D; Gonulal M; Yondem H; Turel Ermertcan A; Sendur N; Topyildiz H; Korkmaz S; Alpsoy E
    Clin Exp Dermatol; 2022 Jan; 47(1):63-71. PubMed ID: 34236713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Local injection of micro-dose anti-interleukin-17A antibody for palmoplantar pustulosis: A real-world study.
    Xia R; Liu J; Gao Y; Diao Z; Chen D; Zhou C; Zhang Z; Yin Z
    Clin Immunol; 2023 Aug; 253():109694. PubMed ID: 37433424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apremilast in Palmoplantar Psoriasis and Palmoplantar Pustulosis: A Systematic Review and Meta-analysis.
    Spencer RK; Elhage KG; Jin JQ; Davis MS; Hakimi M; Bhutani T; Liao W
    Dermatol Ther (Heidelb); 2023 Feb; 13(2):437-451. PubMed ID: 36609960
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the area subscore of the Palmoplantar Pustulosis Area and Severity Index using an attention U-net deep learning algorithm.
    Paik K; Kim BR; Youn SW
    J Dermatol; 2023 Jun; 50(6):787-792. PubMed ID: 36815336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in patients with palmoplantar pustulosis - a Swedish register study.
    Norlin JM; Löfvendahl S; Schmitt-Egenolf M
    Ann Med; 2024 Dec; 56(1):2386524. PubMed ID: 39115530
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Palmoplantar pustulosis - a cross-sectional analysis in Germany.
    Wilsmann-Theis D; Jacobi A; Frambach Y; Philipp S; Weyergraf A; Schill T; Steinz K; Gerdes S; Mössner R
    Dermatol Online J; 2017 Apr; 23(4):. PubMed ID: 28541870
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A multicentre open-label study of apremilast in palmoplantar pustulosis (APLANTUS).
    Wilsmann-Theis D; Kromer C; Gerdes S; Linker C; Magnolo N; Sabat R; Reich K; Mössner R
    J Eur Acad Dermatol Venereol; 2021 Oct; 35(10):2045-2050. PubMed ID: 34077577
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oral alitretinoin treatment in patients with palmoplantar pustulosis inadequately responding to standard topical treatment: a randomized phase II study.
    Reich K; Graff O; Mehta N
    Br J Dermatol; 2016 Jun; 174(6):1277-81. PubMed ID: 26800106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 308-nm excimer light is effective for palmoplantar pustulosis regardless of the presence or absence of focal infection: Single-center real-world experience of treatment for palmoplantar pustulosis.
    Niimura Y; Kamata M; Ishikawa T; Nagata M; Ito M; Watanabe A; Egawa S; Uchida H; Hiura A; Fukaya S; Hayashi K; Fukuyasu A; Tanaka T; Tada Y
    J Dermatol; 2024 Jul; 51(7):977-984. PubMed ID: 38483008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploratory Efficacy Evaluation of Apremilast for the Treatment of Japanese Patients with Palmoplantar Pustulosis: 32-Week Results from a Phase 2, Randomized, Placebo-Controlled Study.
    Okubo Y; Terui T; Kobayashi S; Sano S; Morita A; Imafuku S; Tada Y; Abe M; Yaguchi M; Kimura T; Shimauchi J; Zhang W; Amouzadeh H; Murakami M
    Dermatol Ther (Heidelb); 2024 Jul; 14(7):1863-1873. PubMed ID: 38896381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of serum vascular endothelial growth factor level and findings of nailfold capillaroscopy by dermatoscope in the differential diagnosis of palmoplantar psoriasis and palmoplantar eczema.
    Avcı EB; Erdemir VA; Erdem O; Işık R; Aksu AEK
    Microvasc Res; 2023 Jan; 145():104441. PubMed ID: 36195239
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of systemic methotrexate vs. acitretin in psoriasis patients with significant palmoplantar involvement: a prospective, randomized study.
    Janagond AB; Kanwar AJ; Handa S
    J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e384-9. PubMed ID: 23066720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UVA1 phototherapy in the treatment of palmoplantar pustulosis: a pilot prospective study.
    Su LN; Xu X; Tang L; Yu N; Ding YF
    Lasers Med Sci; 2016 Nov; 31(8):1641-1643. PubMed ID: 27437986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methotrexate monotherapy versus methotrexate and apremilast combination therapy in the treatment of palmoplantar psoriasis: A prospective, randomised, assessor-blinded, comparative study.
    Hassanandani T; Panda M; Jena AK; Raj C
    Indian J Dermatol Venereol Leprol; 2023; 89(2):213-220. PubMed ID: 35841363
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life and comorbidities in palmoplantar pustulosis - a cross-sectional study on 102 patients.
    Trattner H; Blüml S; Steiner I; Plut U; Radakovic S; Tanew A
    J Eur Acad Dermatol Venereol; 2017 Oct; 31(10):1681-1685. PubMed ID: 28252813
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.